to be modulated by cholinergic manipulation in a simiThe above effects have been characterised in terms lar fashion.
Figure 1. Task Design and PeristimulusEvoked BOLD Responses
(A) Schematic time course of three tasks. Each task type consisted of task-specific stimuli at the beginning and end of every trial and a variable intervening delay period (3-14 s of alternating checkerboard) that was identical in stimulus across tasks and in which no motor response occurred. Transients at trial start and end were modeled separately from delay period for each task type, with each task phase being convolved with its own canonical hemodynamic response function. (B) Adjusted data from occipital cortex (averaged over bilateral peaks plotted in Figure  5 , under placebo) showing changes in BOLD response across attention trials for varying delay periods, temporally realigned to each trial onset. Trials were divided according to whether the initial cue was in the visual hemifield contralateral or ipsilateral to the occipital side from which the data was acquired. Note the increasing amplitude and duration of BOLD activity with delay duration reflects delay period activity (higher for attention to contralateral than ipsilateral space), unlike responses to cue or target that are delay independent. Effects reported in this paper reflect the degree to which data fits a standardized delay-dependent regressor for each trial type, similar to the actual profile of activity observed here for contralateral attention (see Experimental Procedures).
to the main effect of attention from that due to stimulus Results alone. An additional and orthogonal question was to determine whether the differential occipital activation Behavioral Data RT and accuracy measures for each subject were subengendered by selective spatial attention (e.g., Martinez et al., 1999) and spatial working memory (Awh et al., mitted to separate repeated-measures ANOVAs with factors of treatment (drug or placebo) and condition 1999) toward either hemifield (versus the opposite hemifield) is itself modulated by physostigmine. We expected (attention, WM, and control; Figure 2 ). RT: subjects were faster under physostigmine relative to placebo over all that the degree of differential response between right and left occipital cortices would either increase or deconditions [F(1,17) ϭ 4.6; p Ͻ 0.05; RTs comparing drug to placebo for attention, WM, and control were 428 vercrease, depending on whether cholinergic enhancement positively or negatively modulated top-down spatial bisus 443 ms; 1014 versus 1047 ms, and 435 versus 457, respectively], but there was no treatment ϫ condition asing of sensory cortices, respectively. Finally, we examined for brain regions that show either a dissociation interaction. A main effect of condition was also apparent [F(1,17) ϭ 107; p Ͻ 0.001], which could be predominantly or similarity in response to physostigmine between attention and working memory, including separate analyaccounted for by WM being slower than attention and control (p Ͻ 0.01). Accuracy: there was no main effect ses of WM encoding and delay periods. Since our experimental design aimed to control for sensorimotor effects of treatment for accuracy. However, a treatment ϫ condition interaction was evident [F(1,17) ϭ 5.7; p Ͻ 0.05], between conditions, we limited our analysis of cholinergic modulation of attention to the period of maintained which reflected physostigmine improving accuracy in attention (86% versus 79% for valid trials; p Ͻ 0.05) but attention between cue and target (which approximates to the construct of "sustained attention"; see Sarter Performance compared across conditions (attention, working memory, and control; valid and invalid cue trials are shown separately) and treatments (placebo and physostigmine). For RTs, a main effect of group existed, suggesting faster responses under physostigmine (individual paired t tests for each task revealed a significant effect only for attention). For accuracy, subjects performed better under physostigmine during attention but not working memory or control (at ceiling), as suggested by a treatment ϫ condition interaction. *p Ͻ 0. Regions within occipital cortex showing main effect of visual stimulation (i.e., delay period activity across all tasks) versus baseline, under placebo, physostigmine, and when comparing treatments for this effect (no occipital areas were greater under physostigmine than placebo for the main effect of visual stimulation). Graphs plot percent signal change from baseline for the three conditions (separating attend right and attend left conditions) in regions showing a main effect of visual stimulation under placebo. Primary visual cortex (calcarine sulcus) showed greater stimulus-evoked activity under placebo than physostigmine, which did not differ significantly across conditions. This effect was unlikely to be due to a general vascular effect of drug, as it was not seen in either lateral occipital cortex that also showed main effects of visual stimulation under placebo (these regions can also be seen to show an effect of condition due to failure of activation during WM but not attention or control). no difference in the false alarm rate between treatments occipital cortices (p Ͻ 0.05, whole-brain corrected). A (overall mean ϭ 4.6%; 1.1%, and 1.6%, for attention, treatment effect was evident in primary visual cortex, WM, and control, respectively).
with physostigmine reducing stimulus-evoked activation compared to placebo (12, Ϫ90, Ϫ6; Z ϭ 4.01; p Ͻ 0.001, uncorrected; i.e., main effect of drug, with no fMRI Data: Effects of Physostigmine treatment ϫ condition interaction; Figure 3 , graph 1).
on Visual Stimulation
Lateral occipital cortices did not show a treatment effect We first examined for visual regions showing stimulus-( Figure 3 , graph 2; treatment ϫ region interaction comevoked activation to the alternating checkerboard paring primary visual and lateral occipital regions was across all three conditions (attention, working memory, p Ͻ 0.005), suggesting that physostigmine did not simand control delay periods) versus baseline. Under both ply change hemodynamic responsiveness across occipplacebo and physostigmine, robust stimulus-evoked activations were evident in primary visual and lateral ital cortex. Figure 4 ; note that the contrast is limited to delay periods of both conditions, in which physostigmine enhanced the degree of activation (relative to control) in both ipsilateral and contralateral extrastimulus was identical and no motor response occurred). The direct comparison of this effect between striate occipital cortices, consistent with a drug-induced enhancement of accuracy across both valid and invalid physostigmine and placebo revealed that these regions were differentially modulated by cholinergic enhancetrials. However, physostigmine was also found to increase activation in (adjacent) extrastriate cortex that ment. Specifically, extrastriate occipital and prefrontal cortices showed enhanced differential activity (blue in was greater on the side ipsilateral than contralateral to the cued hemifield, resulting in a net reduction in Figure 4 ), while superior-medial parietal cortex (green in Figure 4 ; yellow in Figure 6 ) showed reduced differential lateralization of occipital activity. We next determined whether the physostigmineactivity, during attention relative to control, under physostigmine versus placebo. The drug-induced increases induced decrease in occipital lateralization bias with selective spatial attention was associated with a reducin occipital activity with attention, relative to control, were also significant (p Ͻ 0.001) when analyzing attendtion in a behavioral measure of selective spatial processing. Taking each subject's difference in accuracy right and attend-left trials separately (i.e., contralateral and ipsilateral to cued direction; ** in Figure 4) . between valid and invalid cued trials as an invalidity effect, we found a highly significant correlation between Right versus Left-Spatial Attention We next addressed the orthogonal question of whether drug-induced decrease of this behavioral measure and attenuation in occipital activity lateralization reported physostigmine influenced the differential activation of right versus left occipital cortices (and vice versa) as a above (r ϭ 0.70; p ϭ 0.001; Figure 5B ; effect averaged over bilateral occipital peaks of treatment ϫ laterality function of attended location. Under placebo, being cued to either hemifield (versus the opposite hemifield) interaction). In other words, subjects showing greater activation on the occipital side ipsilateral (versus contraactivated contralateral occipital cortex during the subsequent delay period in which a uniform stimulus was lateral) to that cued, under drug, were more sensitive at detecting invalidly (relative to validly) cued targets, unpresented (Table 2 and effect averaged over bilateral occipital peaks showing the fact that the peak signal estimates of both superior occipital regions in Figure 5A were less (p Ͻ 0.05) than treatment ϫ task interaction: Ϫ33, Ϫ87, 0 and 30, Ϫ81, 18). These BOLD-behavioral correlations, together with those observed elsewhere in superior occipital cortex (e.g., Figure 4 ), argues against the possibility that a ceilwas also activated by attention versus control (delayperiods), under placebo, as shown by a conjunction ing in the hemodynamic response could explain the treatment ϫ laterality interactions.
analysis over the two tasks (i.e., regions significantly active in both attention and WM: red in Figure 6A ). However, whereas superior-medial parietal cortex had fMRI Data: Effects of Physostigmine on Spatial Working Memory shown an attenuated differential response to attention versus control under physostigmine versus placebo Spatial Working Memory versus Control The effect of working memory versus control (delay-(yellow in Figure 6A ), there was no drug-induced modulation of this area with WM versus control (treatment x periods), under placebo, engendered activation in parietal and prefrontal cortices (Table 3) . A similar network condition interaction comparing attention and WM just not WM while causing a speeding of response indepenEncoding dent of task. Effects of physostigmine on BOLD activity A previous WM study (Furey et al., 2000a) found that that were selective for attention rather than WM or conphysostigmine enhanced extrastriate occipital activity trol delay periods were evident in extrastriate occipital selectively with face encoding (i.e., study versus test and prefrontal cortices (physostigmine increased the phases), which was interpreted as an effect of cholinereffect of attention versus control) and superior-medial gic enhancement on attention. We were able to test parietal cortex (physostigmine decreased the same effor this possibility in our experiment by examining for fect). Conversely, effects of physostigmine on brain reregions that showed drug-induced enhancement during sponses that were similar across tasks were found in both WM study (versus WM test) and attention delay primary visual cortex (physostigmine reduced re-(versus control delay), using a conjunction analysis over sponses to attention, WM, and control-delay periods). both types of effect. This revealed that bilateral occipital Furthermore, cholinergic modulation of attention and (30, Ϫ81, 18 and Ϫ24, Ϫ84, 12, Z Ն 3.45) and superior WM was similar in the two following respects: physostigparietal (27, Ϫ63, 33, Z ϭ 4.01; p Ͻ 0.001, uncorrected, mine reduced selective occipital activation during both for all) cortices showed enhanced activity under physoattention and WM-delay periods (as a function of prestigmine selectively during both WM encoding and atceding cue or study item laterality) and increased activatention ( Figure 6C ). No visual regions showed the oppotions during both WM-encoding and attention-delay in the same extrastriate regions. site contrast (i.e., reduction of both contrasts by drug). We discount any explanation of our findings in terms relevant stimuli presented for an equally brief duration (attention varying as a function of target number and of general effects of drug on blood oxygenation leveldependent (BOLD) responses. First, all task effects were semantics), whereas in our study targets differed markedly in properties between attention and control. Hence, corrected for session means, which themselves did not differ by treatment across any of the areas highlighted the enhancement of occipital activation by procholinergic modulation may depend upon the difficulty of de-(nor were there treatment effects on global activity or blood pressure). Second, certain treatment ϫ condition tecting task-relevant stimuli as well as on attentional demand. We caution that the use of nicotine, in smokers, interactions (Figures 4-6) can only be explained by recourse to an effect of drug on specific cognitive proin Lawrence et al. makes these two studies not strictly comparable. cesses. In the case of drug effects across all tasks (Figure 3) , we note that the effect reported was specific to only one part of visual cortex, arguing against a general Cholinergic Modulation of Spatial Working Memory change in occipital BOLD responsiveness. Finally, while
In contrast to the wide effects of physostigmine on ata BOLD response ceiling could potentially explain a retention-delay (versus control), physostigmine's moduladuced occipital lateralization under drug, we argue tion of working memory-delay (versus control) was reagainst this on the basis of a behavioral correlation with stricted to inferior prefrontal cortex (see also ., 1999) is directed, independent of stimulus. Since acetylcholine has been tion was raised under physostigmine with attention, the expectation-driven selectivity of activation in the same proposed to be a critical modulator of top-down (taskdriven rather than stimulus-driven) effects (see Sarter region was reduced. These last two (orthogonal) effects were associated with consistent behavioral effects: et al., 2001), we expected to find either an increase or decrease in selective occipital activation during the subjects' scores were higher with physostigmine over all attention trials, but subjects showing greater drugdelay period of both tasks, depending on whether the net effect of acetylcholine was to increase or decrease, induced reduction in occipital lateralization showed a relatively greater benefit during invalid than valid trials. respectively, top-down biasing of sensory processing. We emphasize that this effect is orthogonal to the main Hence, while attentional engagement of higher visual cortex may increase under cholinergic enhancement, effect of physostigmine on attention versus control (that was increased under drug). Our results show that physothe retinotopic selectivity of occipital activation that characterises selective spatial attention may itself distigmine reduced the degree of occipital lateralization associated with both attention and WM, in both hemiminish (at least in the hypercholinergic state, given that our subjects were healthy young adults). spheres. For attention, this effect was due to physostigmine increasing activation disproportionately more on Our study also identified differences and similarities between cholinergic modulation of attention and workthe side ipsilateral than contralateral to the previously cued hemifield (i.e., it favored activation more on the ing memory. Selective effects of physostigmine on attention delay period activity in extrastriate occipital and occipital side representing the visual hemifield in which targets were less expected). Furthermore, the actions superior-medial parietal cortices paralleled a pharmacological dissociation on accuracy between tasks. Howof physostigmine on occipital lateralization and activation of ipsilateral occipital cortex were correlated with ever, physostigmine exerted effects on extrastriate cortex that were similar between attention and WM, concordant behavioral effects (viz. with a reduction in performance discrepancy between valid and invalid trispecifically with analyses of WM encoding rather than delay (see also 
Imaging and Image Processing Task
MRI data were acquired from a 2T VISION system (Siemens, ErOn each session, subjects performed three tasks (spatial attention, langen, Germany) equipped with a head coil. Functional images spatial working memory, and visual control; Figure 1 ) in different were acquired with a gradient echo-planar T2* sequence using blocks and repeated once (e.g., AWCAWC). To minimize order ef-BOLD (blood oxygenation level-dependent) contrast. The acquired fects, treatment and task order were completely counterbalanced image consisted of 33 ϫ 3 mm thickness axial slices that covered across subjects, with task order being repeated across sessions. the entire brain, with an effective repetition time of 2.51 s. The first Furthermore, on each session, subjects were given half-hour pracsix volumes were discarded to allow for T1 equilibration effects. tice with feedback, outside the scanner, prior to drug delivery, and Images were realigned to the first scan of the first session, time were also given 10 min inside the scanner, prior to actual task, to corrected, normalized to a standard echo-planar image template, accustom subjects with scanner environment and noise. There were and smoothed with a Gaussian kernel of 8 mm full-width half-52 trials of each condition per session, with an ITI of 0.5-3.5 s.
maximum. In the attention task, subjects were cued to either right or left visual hemifields (for 2. In order to control for sensorimotor differences between condiequivalent to half the checkerboard area). Subjects were then required to rehearse the locations of the three points while fixating tions and performance between treatments, only contrasts of delay period activity were made (except for testing of drug effects on centrally during presentation of a 3-14 s alternating checkerboard (parameters as for attention task). Following this period, a probe WM encoding-see below). Differences in BOLD signal magnitude between conditions of interest (viz. delay period of all tasks versus point appeared anywhere in the display (for 2.5 s), and subjects had to indicate whether its location was the same as one of the three baseline; attention delay versus control delay; WM delay versus control delay; attention right delay versus attention left delay and studied points (test phase). The WM task is adapted from a blocked fMRI study (Awh et al., 1999) in which lateralized occipital responses vice versa) were calculated for each subject and treatment before being submitted to one-sample t tests with generation of statistical (regions of interest) were found contralateral to the visual field in which studied items were presented during a spatial but not object parametric maps (SPMs) of the t statistic. Comparisons of these contrasts were then made between treatments (treatment ϫ condi-WM task.
Visual control trials resembled attention and WM trials in temporal tion interactions). The interaction of treatment ϫ condition, comparing specifically attention with WM, was restricted to within 12 mm composition, with a 3-14 s delay period of alternating checkerboard, during which subjects fixated centrally. However, trials began with (the estimated smoothness) of those coordinates also showing interactions of treatment ϫ condition comparing either attention or WM a central cue for 2.1 s and ended with a prominent central triangle on a plain background for 2.5 s, at which subjects had been inwith control. In order to test for regions showing both attention and working memory activity, contrasts of each condition versus its own structed to press the first key, with no emphasis on speed (hence requiring minimal attention).
set of control trials, under placebo, for each subject were submitted to repeated-measures ANOVA corrected for nonsphericity (Glaser et The use of variable-duration delay periods enabled us to model this temporal component of brain activity (in which the stimulus al., 2001). A conjunction analysis was then performed over contrasts from both conditions (Price and Friston, 1997). Similar analyses were remained identical across conditions and there was no motor response) separately from transients at either end of the delay period performed to test the hypotheses that physostigmine modulates selective occipital activation with both spatial attention and spatial (which varied between conditions and group-the latter due to drug effects on response). By employing a wide range of delay durations WM laterality, and that physostigmine modulates both attention (attention delay versus control delay) and WM encoding responses and modeling the delay periods of false alarm and saccade trials separately, the modeled time series of transients and delay periods (study versus test phases) in the same regions. We report areas that achieve p Ͻ 0.05 significance after correction for whole brain (derived from convolving successive stimulus boxcars with the hemodynamic response function) are sufficiently decorrelated to enor 12 mm radius spheres centered on MNI coordinates derived from equivalent contrasts in previous nonpharmacological studies able efficient estimation of the independent effects of each task component (see also Rowe and Passingham, 2001 
